May 10


AMSTERDAM, May 10, 2011 - Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, provided today a status update on Glybera (alipogene tiparvovec), its gene therapy product under development for the treatment of lipoprotein lipase deficiency (LPLD).

MARNE-LA- VALLEE, France, May 10, 2011 - Reports First Half Results Six Months Ended March 31, 2011 - Total Revenues increased 8% to EUR 559 million, due to higher Resort volumes and average spending per room - EBITDA increased EUR 18 million to EUR 25 million - Net loss narrowed by EUR 15 million to EUR 99 million - Repayment of EUR 46 million of debt during the First Half Euro Disney S.C.A.

BUDAPEST, Hungary, May 10, 2011 - eHealth Week 2011, the largest annual gathering of the European eHealth communities, today opened its gates in Budapest, Hungary, with the motto "Investing in the healthcare systems of the future".

CHICAGO, May 10, 2011 - Orbitz Worldwide (NYSE: OWW) today announced that Eurostar International, the leading provider of international high-speed passenger rail transit across inter-continental Europe, has launched the Orbitz Worldwide Distribution private label solution to power hotel, dynamic packaging, car hire and activities bookings on its website, www.eurostar.com.

PARIS, May 10, 2011 - Brainlab has received 510(k) clearance from the U.S.
Older News
S M T W T F S
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
Copyright© 2011 The Gaea Times